This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Meherji A. Oshtory, MD; Nazhiyath Vijayan, MD

Arch Neurol. 1980;37(2):119-120.

Abstract
• Nocturnal myoclonus has been identified as a cause of disturbed sleep and excessive daytime fatigue. To our knowledge, no therapy has heretofore been available to adequately control this problem. We identified this problem clinically in two patients; in one, the phenomenon was observed with a polygraphic sleep recording. Small doses of clonazepam, 1 mg, before retiring were found to specifically control the myoclonus and allow sleep patterns to return to normal.

Author Affiliations
From the Department of Neurology and the EEG Laboratory, University of California, Davis, Medical Center, Sacramento.

Footnotes
Accepted for publication Jan 7, 1979.

Reprint requests to EEG Laboratory, University of California, Davis, Medical Center, 2315 Stockton Blvd, Sacramento, CA 95817 (Dr Vijayan).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Benign Neonatal Sleep Myoclonus Mimicking Status Epilepticus
Turanli et al.
J Child Neurol 2004;19:62-63.
ABSTRACT  

Benign Neonatal Sleep Myoclonus: Relationship to Sleep States
Resnick et al.
Arch Neurol 1986;43:266-268.
ABSTRACT  

Valproic Acid in the Treatment of Nonepileptic Myoclonus: Report of Three Cases
Sotaniemi
Arch Neurol 1982;39:448-449.
ABSTRACT